UK Regulator Cites CluePoints’ Solutions In Updated Guidance
CluePoints has been cited in the updated Good Clinical Practice (GCP) guidance from the UK’s MHRA, putting the agency´s weight behind CluePoints’ statistical monitoring solutions.
The document, Oversight and Monitoring Activities, covers a broad range of clinical trial activities, including the use of committees to manage trials or review emerging safety data, the central review of clinical trial data, data management processes, and pharmacovigilance signal detection.
Read more about the updated guidance here.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
